Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EYA transcriptional coactivator and phosphatase 3 (EYA3) is a member of the Eyes absent (EYA) family, uniquely defined by dual functionality as a transcriptional coactivator and a protein phosphatase. Its C-terminal EYA domain confers tyrosine phosphatase activity, critical for dephosphorylating the 'Tyr-142' residue of histone H2AX, thereby promoting DNA repair and modulating apoptotic responses. Its N-terminal domain associates with the PP2A holoenzyme, imparting threonine phosphatase activity that regulates key cell cycle proteins such as c-Myc, stabilizing them and promoting cell proliferation, motility, and survival. EYA3 serves as a transcriptional coactivator, partnering with SIX1 and related proteins to regulate transcription and developmental processes. Aberrant EYA3 activity or expression is implicated in diverse pathologies, most notably metastatic cancers and developmental syndromes, making it a candidate therapeutic target under ongoing investigation.
Inhibitors would block phosphatase activity (tyrosine and threonine) and transcriptional coactivation, affecting cell proliferation, survival, and DNA repair, thereby reducing tumor growth/metastasis. Mechanism is context-dependent; modulation of PP2A interaction disrupts threonine phosphatase function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EYA transcriptional coactivator and phosphatase 3 (EYA3).